Suture of the Ovary After Enucleation of Ovarian Endometrioma (SOAVE-1)
Primary Purpose
Endometrioma
Status
Not yet recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Suture of the ovarian cortex
No suture of the ovarian cortex
Sponsored by
About this trial
This is an interventional treatment trial for Endometrioma focused on measuring Endometrioma, Laparoscopy, Suture, Ovary
Eligibility Criteria
Inclusion Criteria:
- Women affected by one primary (no recurrent) monolateral ovarian endometrioma, with maximum diameter between 5 and 10 cm, undergoing laparoscopic enucleation by stripping technique;
- Normal AFC at the enrollment (baseline).
Exclusion Criteria:
- Any other disease;
- Bilateral endometriomas;
- Deep infiltrating endometriosis;
- No previous pelvic surgery (even not gynecological);
- Any other pharmacologic and non pharmacologic treatment in the previous 3 months (wash-out period);
Sites / Locations
- "Filippo Del Ponte" Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
Suture
No suture
Arm Description
Women undergoing suturing of the ovarian cortex after laparoscopic enucleation of endometriomas.
Women undergoing laparoscopic enucleation of endometriomas without subsequent suture of the ovarian cortex.
Outcomes
Primary Outcome Measures
Antral Follicle Count (AFC)
AFC will be evaluated on day 3 of the cycle by a transvaginal ultrasound. Initially the ovarian volume of both the ovaries is calculated. Further the number of small antral follicles in both the ovaries is measured. These follicles could vary in size from 2-10 mm.
Secondary Outcome Measures
Pulsatility index, evaluated by Doppler flowmetry, of the ovarian artery
Evaluation of the pulsatility index (PI; minimum: 0; maximum: 7; higher values represent a better outcome) of the ovarian artery.
Resistive index, evaluated by Doppler flowmetry, of the ovarian artery
Evaluation of the resistive index (RI minimum: 0; maximum: 3; higher values represent a worse outcome) of the ovarian artery.
Ovarian volume
Evaluation of the ovarian volume calculated using the prolate ellipsoid formula (length x height x width x 0.523)
Full Information
NCT ID
NCT03788720
First Posted
October 11, 2018
Last Updated
April 28, 2021
Sponsor
Università degli Studi dell'Insubria
1. Study Identification
Unique Protocol Identification Number
NCT03788720
Brief Title
Suture of the Ovary After Enucleation of Ovarian Endometrioma
Acronym
SOAVE-1
Official Title
Comparison Between Suture of the Ovary Versus no Suture After Enucleation of Ovarian Endometrioma
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 2023 (Anticipated)
Primary Completion Date
May 2025 (Anticipated)
Study Completion Date
May 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Università degli Studi dell'Insubria
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Endometriosis is an estrogen-dependent chronic disease, characterized by the presence of ectopic endometrial-like tissue outside the uterine cavity.
According to the most updated guidelines of the European Society of Human Reproduction and Embryology (ESHRE), infertile women with endometriomas smaller than 3 cm should be addressed directly to Assisted Reproduction Technology (ART); conversely, for infertile women with endometriomas larger than 3 cm, enucleation of ovarian endometriomas could be considered in order to improve reproductive outcomes (both spontaneous and ART pregnancy rate).
To date, literature data do not allow to draw a firm conclusion about the best strategy to reduce ovarian damage during enucleation of ovarian endometriomas: in particular, investigators still lack robust evidence in order to choose between suturing the ovary or not after the enucleation.
In this scenario, the aim of our the study will be to compare functional outcomes of the ovary in a group of women undergoing suturing of the ovarian cortex after laparoscopic enucleation of endometriomas (cases) and a group of women undergoing laparoscopic enucleation of endometriomas without subsequent suture of the ovarian cortex.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endometrioma
Keywords
Endometrioma, Laparoscopy, Suture, Ovary
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Surgeons who perform the surgery will be not masked for the treatment allocation.
Evaluators (sonographers, data analyzers) will be blind for the treatment allocation.
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Suture
Arm Type
Experimental
Arm Description
Women undergoing suturing of the ovarian cortex after laparoscopic enucleation of endometriomas.
Arm Title
No suture
Arm Type
Sham Comparator
Arm Description
Women undergoing laparoscopic enucleation of endometriomas without subsequent suture of the ovarian cortex.
Intervention Type
Procedure
Intervention Name(s)
Suture of the ovarian cortex
Intervention Description
Suture of the ovarian cortex after laparoscopic enucleation of endometriomas, using one single monofilament suture material, continuous suture technique with maximum 5 transfixion of the ovarian cortex and intracorporeal knots only (no extracorporeal knots).
Intervention Type
Procedure
Intervention Name(s)
No suture of the ovarian cortex
Intervention Description
Laparoscopic enucleation of endometriomas without suture of the ovarian cortex
Primary Outcome Measure Information:
Title
Antral Follicle Count (AFC)
Description
AFC will be evaluated on day 3 of the cycle by a transvaginal ultrasound. Initially the ovarian volume of both the ovaries is calculated. Further the number of small antral follicles in both the ovaries is measured. These follicles could vary in size from 2-10 mm.
Time Frame
Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery
Secondary Outcome Measure Information:
Title
Pulsatility index, evaluated by Doppler flowmetry, of the ovarian artery
Description
Evaluation of the pulsatility index (PI; minimum: 0; maximum: 7; higher values represent a better outcome) of the ovarian artery.
Time Frame
Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery
Title
Resistive index, evaluated by Doppler flowmetry, of the ovarian artery
Description
Evaluation of the resistive index (RI minimum: 0; maximum: 3; higher values represent a worse outcome) of the ovarian artery.
Time Frame
Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery
Title
Ovarian volume
Description
Evaluation of the ovarian volume calculated using the prolate ellipsoid formula (length x height x width x 0.523)
Time Frame
Change from day 3 of the menstrual cycle prior to the elective laparoscopic surgery to day 3 of the menstrual cycle after to the elective laparoscopic surgery
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Women affected by one primary (no recurrent) monolateral ovarian endometrioma, with maximum diameter between 5 and 10 cm, undergoing laparoscopic enucleation by stripping technique;
Normal AFC at the enrollment (baseline).
Exclusion Criteria:
Any other disease;
Bilateral endometriomas;
Deep infiltrating endometriosis;
No previous pelvic surgery (even not gynecological);
Any other pharmacologic and non pharmacologic treatment in the previous 3 months (wash-out period);
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Antonio Simone Laganà, M.D.
Phone
+393296279579
Email
antoniosimone.lagana@asst-settelaghi.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Antonio Simone Laganà, M.D.
Organizational Affiliation
Università degli Studi dell'Insubria
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Fabio Ghezzi, M.D.
Organizational Affiliation
Università degli Studi dell'Insubria
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Jvan Casarin, M.D.
Organizational Affiliation
Università degli Studi dell'Insubria
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Simone Garzon
Organizational Affiliation
Università degli Studi dell'Insubria
Official's Role
Principal Investigator
Facility Information:
Facility Name
"Filippo Del Ponte" Hospital
City
Varese
ZIP/Postal Code
21100
Country
Italy
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Antonio Simone Laganà, M.D.
Phone
+393296279579
Email
antoniosimone.lagana@asst-settelaghi.it
First Name & Middle Initial & Last Name & Degree
Davide Sturla, M.D.
First Name & Middle Initial & Last Name & Degree
Giulia Bordi, M.D.
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Suture of the Ovary After Enucleation of Ovarian Endometrioma
We'll reach out to this number within 24 hrs